Partnering to Capitalize on the Potential
Our platform enables expansive opportunities across multiple therapeutic areas and modalities. Given the enormity of the potential, we can’t do it all alone. We intend for our approach and unparalleled understanding of transcriptional machinery and gene expression to revolutionize how our industry approaches drug discovery and development.
Partnering with biopharma companies with expertise in a given therapeutic area or modality is integral to maximizing the potential of our platform for patients. Our aim is to empower partners with a rapid, efficient approach to targeting the diseases that matter most to them.